Hyperkalemia and hospitalization

NEW YORK, June 20 (Praxis Press) Criteria for deciding whether patients with hyperkalemia should be treated in a hospital or as an outpatient have not been well established. Charytan and colleagues examined the current practices regarding hospitalization of patients with hyperkalemia and evaluated the criteria for admission. To perform the study they evaluated 11 patients hospitalized for hyperkalemia and compared them to 12 patients with a similar degree of hyperkalemia who were treated as outp

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, June 20 (Praxis Press) Criteria for deciding whether patients with hyperkalemia should be treated in a hospital or as an outpatient have not been well established. Charytan and colleagues examined the current practices regarding hospitalization of patients with hyperkalemia and evaluated the criteria for admission. To perform the study they evaluated 11 patients hospitalized for hyperkalemia and compared them to 12 patients with a similar degree of hyperkalemia who were treated as outpatients. The researchers found that the justification for the decision to admit patients to the hospital or to treat them as outpatients was often not evident. The criteria for hospitalization suggested by the researchers include severe hyperkalemia (8.0 mmol/L, with changes other than peaked T waves on the electrocardiogram), acute worsening of renal function, and supervening medical problems. Patients with severe hyperkalemia should be admitted to a hospital.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform